DE69512374D1 - Zusammensetzungen, die troxerutin als komplex mit phosphatidylcholin enthalten, zur topischen behandlung von erektionsimpotenz - Google Patents

Zusammensetzungen, die troxerutin als komplex mit phosphatidylcholin enthalten, zur topischen behandlung von erektionsimpotenz

Info

Publication number
DE69512374D1
DE69512374D1 DE69512374T DE69512374T DE69512374D1 DE 69512374 D1 DE69512374 D1 DE 69512374D1 DE 69512374 T DE69512374 T DE 69512374T DE 69512374 T DE69512374 T DE 69512374T DE 69512374 D1 DE69512374 D1 DE 69512374D1
Authority
DE
Germany
Prior art keywords
pct
phosphatidylcholine
complex
topical treatment
impotence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69512374T
Other languages
English (en)
Other versions
DE69512374T2 (de
Inventor
Sergio Curri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Inpharma SA
Original Assignee
Inpharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH02454/94A external-priority patent/CH688884A5/it
Priority claimed from CH03809/94A external-priority patent/CH688883A5/it
Application filed by Inpharma SA filed Critical Inpharma SA
Application granted granted Critical
Publication of DE69512374D1 publication Critical patent/DE69512374D1/de
Publication of DE69512374T2 publication Critical patent/DE69512374T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/543—Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
    • A61K47/544—Phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69512374T 1994-08-05 1995-07-25 Zusammensetzungen, die troxerutin als komplex mit phosphatidylcholin enthalten, zur topischen behandlung von erektionsimpotenz Expired - Lifetime DE69512374T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH02454/94A CH688884A5 (it) 1994-08-05 1994-08-05 Composizione farmaceutica a base di troxerutina per il trattamento topico dell' impotenza erettiva peniena di origine microvascolare.
CH03809/94A CH688883A5 (it) 1994-12-16 1994-12-16 Composizione farmaceutica a base di prostaglandina E1 per il trattamento topico dell' impotenza erettiva peniena su base vascolare.
PCT/IB1995/000584 WO1996003991A1 (en) 1994-08-05 1995-07-25 Compositions containing prostaglandin e1 and/or troxerutine complexed with phosphatidylcholine for topical treatment of erectile impotence

Publications (2)

Publication Number Publication Date
DE69512374D1 true DE69512374D1 (de) 1999-10-28
DE69512374T2 DE69512374T2 (de) 2000-05-11

Family

ID=25690490

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69512374T Expired - Lifetime DE69512374T2 (de) 1994-08-05 1995-07-25 Zusammensetzungen, die troxerutin als komplex mit phosphatidylcholin enthalten, zur topischen behandlung von erektionsimpotenz

Country Status (12)

Country Link
US (1) US6013277A (de)
EP (1) EP0722323B1 (de)
JP (1) JP3901213B2 (de)
KR (1) KR100422191B1 (de)
CN (1) CN1101192C (de)
AT (1) ATE184794T1 (de)
BR (1) BR9506301A (de)
DE (1) DE69512374T2 (de)
DK (1) DK0722323T3 (de)
ES (1) ES2141950T3 (de)
GR (1) GR3032251T3 (de)
WO (1) WO1996003991A1 (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5718917A (en) * 1995-12-15 1998-02-17 Harvard Scientific Corporation PGE-1 containing lyophilized liposomes for use in the treatment of erectile dysfunction
GR1002847B (el) 1997-05-06 1998-01-27 Χρηση της μισοπροστολης ή/και της μισοπροστολης οξυ για την παρασκευη φαρμακευτικου προιοντος για τη θεραπευτικη αντιμετωπιση των δυσλειτουργιων της στυσεως
IS4518A (is) * 1997-07-09 1999-01-10 Lyfjathroun Hf, The Icelandic Bio Pharmaceutical Group Nýtt lyfjaform fyrir bóluefni
AU3713600A (en) * 1999-03-01 2000-09-21 Nitromed, Inc. Nitrosated and nitrosylated prostaglandins, compositions and metods of use
KR100402334B1 (ko) 2000-06-23 2003-10-22 환인제약 주식회사 알프로스타딜 외용제
US20040018237A1 (en) 2002-05-31 2004-01-29 Perricone Nicholas V. Topical drug delivery using phosphatidylcholine
AU2003251486A1 (en) * 2002-06-12 2003-12-31 Joseph Arezzo A non-invasive, quantitative somatosensory method for the evaluation of erectile dysfunction
US6855332B2 (en) * 2002-07-03 2005-02-15 Lyfjathroun Hf. Absorption promoting agent
CA2830298C (en) 2011-03-17 2016-08-16 Transdermal Biotechnology, Inc. Topical nitric oxide systems comprising lecithin and methods of use thereof
US8871261B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Cancer treatments and compositions for use thereof
US8871258B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Treatment and prevention of learning and memory disorders
US8871262B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Compositions and methods for treatment of osteoporosis and other indications
US8871255B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Treatment of skin and soft tissue infection with nitric oxide
US8871254B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system
US8871257B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery
US8871260B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Methods and compositions for muscular and neuromuscular diseases
US8871259B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Techniques and systems for treatment of neuropathic pain and other indications
US8871256B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Methods and systems for treatment of inflammatory diseases with nitric oxide
US9295637B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Compositions and methods for affecting mood states
US9314423B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Hair treatment systems and methods using peptides and other compositions
US9387159B2 (en) 2013-03-13 2016-07-12 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US9295636B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US9393265B2 (en) 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US9724419B2 (en) 2013-03-13 2017-08-08 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US9314417B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US9295647B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US9393264B2 (en) 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US9241899B2 (en) 2013-03-13 2016-01-26 Transdermal Biotechnology, Inc. Topical systems and methods for treating sexual dysfunction
US20140271937A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US9320758B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US9339457B2 (en) 2013-03-13 2016-05-17 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US9687520B2 (en) 2013-03-13 2017-06-27 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US9314422B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US20140271731A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US9750787B2 (en) 2013-03-13 2017-09-05 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US20140271938A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US9320706B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US9314433B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US9849160B2 (en) 2013-03-13 2017-12-26 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
WO2022155341A1 (en) * 2021-01-13 2022-07-21 Dyve Biosciences, Inc. Transdermal formulations for phosphodiesterase-5 inhibitors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60260524A (ja) * 1984-06-07 1985-12-23 Nakanishi Michio プロスタグランジン系化合物の非脂肪乳剤製剤
US5256652A (en) * 1987-11-12 1993-10-26 Pharmedic Co. Topical compositions and methods for treatment of male impotence
IT1247678B (it) * 1990-05-31 1994-12-28 Alberto Reale Metodo per la cura dell'impotenza erettiva maschile
DE4125255A1 (de) * 1991-07-31 1993-02-04 Knoll Ag Prostaglandin e (pfeil abwaerts)1(pfeil abwaerts)-formulierung
EP0711148B1 (de) * 1993-07-28 2000-08-30 Pharmaderm Laboratories Ltd. Zweiphasige multilamellare lipidvesikel
US5482039A (en) * 1994-03-25 1996-01-09 Vivus, Inc. Process for diagnosing erectile dysfunction, and related methods of treatment

Also Published As

Publication number Publication date
CN1101192C (zh) 2003-02-12
CN1131912A (zh) 1996-09-25
KR100422191B1 (ko) 2004-05-20
JPH09503529A (ja) 1997-04-08
US6013277A (en) 2000-01-11
EP0722323B1 (de) 1999-09-22
ATE184794T1 (de) 1999-10-15
GR3032251T3 (en) 2000-04-27
EP0722323A1 (de) 1996-07-24
JP3901213B2 (ja) 2007-04-04
ES2141950T3 (es) 2000-04-01
KR970701049A (ko) 1997-03-17
DK0722323T3 (da) 2000-04-03
DE69512374T2 (de) 2000-05-11
WO1996003991A1 (en) 1996-02-15
MX9601298A (es) 1998-12-31
BR9506301A (pt) 1997-08-05

Similar Documents

Publication Publication Date Title
DE69512374D1 (de) Zusammensetzungen, die troxerutin als komplex mit phosphatidylcholin enthalten, zur topischen behandlung von erektionsimpotenz
DK0880350T3 (da) Behandling af dissemineret sklerose
EE9700008A (et) Uus ravimpreparaat valu vaigistamiseks
DE69021214T2 (de) Orale zusammensetzung für die behandlung intestinaler entzündlicher krankheiten.
AR009407A1 (es) Uso de progesterona para preparar una composicion farmaceutica util para tratar o reducir la isquemia y/o una enfermedad arterial coronaria y/o laincidencia de acontecimientos cardiovasculares
MX9603596A (es) Perfluoropolieteres o composiciones de los mismos para prevencion y tratamiento de infecciones virales topicas.
MX9505181A (es) Utilizacion de un antagonista de la substancia p en una composicion farmaceutica para tratar desordenes de la piel de origen neurogenico.
ATE314068T1 (de) Behandlung von seborrhoischer dermatitis
UA35611C2 (uk) Композиція місцевого застосування для інгібування росту волос у ссавців, спосіб із її використанням та композиція місцевого застосування для доставки водорозчинного фармакологічного засобу до шкіри
RS49599B (sr) Upotreba inhibitora h+, k+-atp-aze i glukokortikoida i farmaceutska formulacija
TR199900661T2 (xx) Cilt enfeksiyonlar�n�n tedavisi amac�yla 1-hidroksi-2-piridonlar�n kullan�m�
KR950016760A (ko) 치질 치료제
DK0773782T3 (da) Terpenderivater (sarcodictyiner) anvendelse som antitumormidler
KR910009267A (ko) 우울증의 치료방법
ES2159294T3 (es) Metodo y composicion para el tratamiento de la caida del cabello.
FR2734724B1 (fr) Application de derives de pyrrolidine a la preparation de medicaments destines au traitement de l'alcoolisme
ATE233085T1 (de) Arzneimittel zur topischen anwendung
SE9700617D0 (sv) New composition
DE69626691D1 (de) Komponente b als wundheilendes mittel
RU95103161A (ru) Способ лечения хронической гепатитов
MX9700626A (es) USO DE AZASPIRANOS EN LA REPARACIaN DE COMPOSICIONES PARA TRATAR INFECCIONES OPORTUNISTAS.
GEU2000587Y (en) Medicinal Ointment Turmanidze-Burduli Derma
MD950121A (ro) Metodă de tratare a urmărilor ictusurilor ischemice
GEU1997310Y (en) Medicinal Ointment “Uznadze-Mchedlishvili 3”
TW238246B (en) Pharmaceutical composition for reducing the renal toxicity and enhancing the effect of antitumor

Legal Events

Date Code Title Description
8364 No opposition during term of opposition